Clinical Trial Update: Study Evaluating the Safety and Ability to Produce Immune Response of Prevenar and Meningitec Given at the Same Time [Phase 4]

View source ↗

Summary

Phase 4 study assessing the safety and immunogenicity of administering Prevnar (Prevenar) and Meningitec together in healthy participants; the trial has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease
• Pneumococcal Disease

Drugs mentioned

• Meningitec (Meningococcal conjugate vaccine)
• Prevenar (pneumococcal conjugate vaccine)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Healthy | Phase 4 | Status: COMPLETED